RSS feed Add to your Facebook page LinkedIn Watch us on Youtube
  
  
  
  
Access
  
$$MP-HFM-239-COVER.pdf
  
Cover Pages10/1/2014Open Access
$$MP-HFM-239-ES.pdf
  
Executive Summary and Synthèse10/1/2014Open Access
$$MP-HFM-239-T.pdf
  
Technical Evaluation Report10/1/2014Open Access
$MP-HFM-239-PC.pdf
  
Programme Committee10/1/2014Open Access
MP-HFM-239-01.doc
  
Beyond the Dirty Dozen: A Matrix Methodology for Assessing Future Biowarfare Threats10/1/2014Open Access
MP-HFM-239-02.docx
  
Medical Countermeasures – Regulatory Challenges10/1/2014Open Access
MP-HFM-239-03.doc
  
Current Progress Towards FDA Licensure of the rF1V Plague Vaccine10/1/2014Open Access
MP-HFM-239-04.doc
  
Status of the JPEO-CBD Recombinant Botulinum Vaccine A/B (rBV A/B) Program10/1/2014Open Access
MP-HFM-239-05.doc
  
Anthrax Vaccine Adsorbed: Evidence on Safety, Immunogenicity, and Continuing the Vaccination Series When Doses Are Delayed10/1/2014Open Access
MP-HFM-239-06.doc
  
Progress towards Development of a Safe and Efficacious Ricin Vaccine10/1/2014Open Access
MP-HFM-239-07.docx
  
Individual and Multiagent DNA Vaccines Delivered by Electroporation Elicit Protective Immunity against Aerosolized Venezuelan, Eastern and Western Equine Encephalitis Viruses in Nonhuman Primates10/1/2014Open Access
MP-HFM-239-08.doc
  
Venezuelan Equine Encephalitis Replicon (VRP) Vaccine Development for Ebola and Marburg Viruses10/1/2014Open Access
MP-HFM-239-09.doc
  
Current to Future Molecular Diagnostics: A Roadmap from Inception to Regulatory Compliance10/1/2014Open Access
MP-HFM-239-10.doc
  
Civilian-Military Cooperation for Detection, Identification, and Confirmation of Biological Agents10/1/2014Open Access
MP-HFM-239-11.doc
  
Peptide-Based Fluorescence Resonance Energy Transfer Protease Substrates for the Detection and Diagnosis of Bacillus Species10/1/2014Open Access
MP-HFM-239-12.doc
  
Antimicrobial Peptides: A Promising Class of Antimicrobial Compounds against BWA and Multi-Drug Resistant Bacteria - In the spotlight: The Lactoferrin Chimera;10/1/2014Open Access
MP-HFM-239-13.doc
  
Characterization of a Fluoroquinolone-Resistant Strain of Francisella Tularensis10/1/2014Open Access
MP-HFM-239-14.doc
  
Multi-drug Resistant Gram Negative Bacteria as Potential Biological Agent, How to Circumvent the Membrane-Barrier Strategy10/1/2014Open Access
MP-HFM-239-15.doc
  
The Anthrax Capsule: Target for Novel Therapeutics and New Vaccines10/1/2014Open Access
MP-HFM-239-16.doc
  
Development of Recombinant Antibodies for Biodefense using Phage Display10/1/2014Open Access
MP-HFM-239-17.docx
  
Development of Therapeutic Antibodies as Medical Countermeasures to Biological Agents in Defense Research and Development Canada Suffield Research Centre10/1/2014Open Access
MP-HFM-239-18.doc
  
A Multinational Consortium for the Development of Therapeutic Antibodies to Tier 1 Bioterrorism Agents: Protective scFv-Fc Antibody against Marburg Virus derived from Macaque Immune Library;10/1/2014Open Access
MP-HFM-239-19.doc
  
Supportive Care for Filovirus Management: Challenges and Opportunities10/1/2014Open Access
MP-HFM-239-20.doc
  
Development of a Brucella melitensis Large Animal Model and Assessment of Antimicrobial Treatment10/1/2014Open Access
MP-HFM-239-21.doc
  
Development and Characterization of Burkholderia mallei and B. pseudomallei Animal Models to Support Future Downstream Testing and Evaluation of Vaccines and Countermeasures10/1/2014Open Access
MP-HFM-239-22.doc
  
Development and Characterization of a Burkholderia pseudomallei Large Animal Model to Support the Licensure of Medical Countermeasures10/1/2014Open Access
MP-HFM-239-23.doc
  
The Role of Tat Proteins in Yersinia pestis Pathogenesis10/1/2014Open Access
MP-HFM-239-24.doc
  
Proteomic Analysis of RAW264.7 Mouse Macrophage Cells Infected with Burkholderia pseudomallei10/1/2014Open Access
MP-HFM-239-25.doc
  
Legionella pneumophila: A Biological Threat Model Bacterium. Studies of Factors that May Cause Disorientation and Delirium in Patients10/1/2014Open Access